Aamir Suhail

Dr. Aamir Suhail

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Nature
Verified
Journal Article
Closed access
PDF file
KKKimitoshi Kimura
Kimitoshi Kimura
ASAyshwarya Subramanian
Ayshwarya Subramanian
ZYZhuoran Yin
Zhuoran Yin
AKAhad Khalilnezhad
Ahad Khalilnezhad
YWYufan Wu
Yufan Wu
VKVijay K. Kuchroo
Vijay K. Kuchroo

Verified
Journal Article
Open access
PDF file
Sudhir KumarSudhir Kumar
Sudhir Kumar
JCJagdish Chand
Jagdish Chand
PSPreeti Sharma
Preeti Sharma
SSSudhakar Singh
Sudhakar Singh
PKPukar Khanal
Pukar Khanal
SMSonam Mittal
Sonam Mittal
Metastasis remains the leading cause of cancer deaths, heavily influenced by aging-related biological processes. As global life expectancy increases, cancer incidence and progression complexity in older adults also rise, emphasizing the urgent need to understand how the aging tumor microenvironment (TME) promotes metastasis. This review explores the molecular and cellular mechanisms behind metastatic development in the aged TME, focusing on the combined impacts of cellular senescence, chronic inflammation (inflammaging), immune system decline, extracellular matrix (ECM) changes, and abnormal blood vessel growth. Aging causes an accumulation of senescent cells that secrete a range of cytokines, growth factors, and enzymes (SASPs), which remodel the ECM, making it stiffer and more degradable, and activate pro-metastatic pathways like TGF-β, STAT3, and MAPK, aiding processes like EMT and tumor invasion. Meanwhile, persistent low-grade inflammation attracts immunosuppressive cells, and immune decline hampers tumor surveillance, allowing cancer cells to evade immune detection. The aged TME also undergoes significant vascular and metabolic changes, such as abnormal angiogenesis and hypoxia, supporting the growth of more aggressive, treatment-resistant cancer clones and spreading metastases. These changes are driven by hallmarks of molecular aging, including telomere shortening, oxidative DNA damage, and epigenetic alterations, which lead to genetic instability and turn the aged stroma into fertile ground for metastasis. The review also discusses new therapeutic approaches, including senolytics, anti-inflammatory treatments, immune system rejuvenation, and metabolic strategies, highlighting the importance of age-specific models and precision medicine to enhance outcomes for the growing number of elderly cancer patients.

6 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YRYesheswini Rajendran
Yesheswini Rajendran
Bhagyashree SrivastavaBhagyashree Srivastava
Bhagyashree Srivastava
PGPreksha Gaur
Preksha Gaur
RBRohan Babar
Rohan Babar
NGNeha Guliya
Neha Guliya
CSChittur V. Srikanth
Chittur V. Srikanth
Inflammatory bowel disease (IBD), comprising Ulcerative colitis (UC) and Crohn’s Disease, is a chronic relapsing immune-mediated inflammatory disorder of the gut. The intestinal mucus layer is a protective barrier that safeguards direct exposure of epithelium to luminal microbes and antigens. A prolonged disruption of the mucus layer may contribute to the development of IBD. Loss of mucin-producing goblet cells is a hallmark of UC. The underlying molecular mechanism controlling goblet regulation remains poorly understood. In the current work, we show a key role for NCoR1 (Nuclear corepressor 1) in goblet cell regulation. A specific downregulation of NCoR1 in intestinal crypts and goblet cells was observed in human UC and mice models. While NCoR1 was upregulated during goblet cell differentiation, inflammatory cues downregulated its expression. Experimental loss of NCoR1 resulted in exacerbated disease in a murine model of colitis, whereas its upregulation via Vitamin D led to a rescue. ChIP-seq led to the identification of KLF-16, a transcription factor, as a target of NCoR1. NCoR1 -KLF16 regulatory axis regulated key goblet cell proteins, including MUC2. Mechanistically, the regulation of MUC2 is modulated by the NCoR1-KLF16 axis, via mTOR signalling. In conclusion, this work shows a critical involvement of NCoR1-KLF16 in governing goblet cell function and intestinal homeostasis.

22 November 2025
Verified
Book Chapter
Closed access
PDF file
PUPrabhat Upadhyay
Prabhat Upadhyay
ASAamir Suhail
Aamir Suhail
Sudhir KumarSudhir Kumar
Sudhir Kumar

31 March 2026 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
KAKieran R. Adam
Kieran R. Adam
ASAamir Suhail
Aamir Suhail
VKVijay K. Kuchroo
Vijay K. Kuchroo
DVDario A.A. Vignali
Dario A.A. Vignali
Inhibitory receptors (IRs) such as CTLA-4, PD-1, LAG3, TIM-3, and TIGIT are critical regulators of immune homeostasis, functioning to restrain excessive immune activation and prevent autoimmunity. While the blockade of IRs has transformed cancer immunotherapy by reinvigorating antitumor T cell responses, emerging strategies aim to harness the immunosuppressive potential of these receptors for treating autoimmune and inflammatory diseases. Agonistic antibodies that activate IR signaling have demonstrated promising results in preclinical models by promoting immune tolerance and suppressing pathological effector T cell functions. This review highlights recent progress in the development of agonistic IR-targeted therapies, examining their mechanisms of action, therapeutic efficacy, and the translational challenges that must be addressed to bring these innovative approaches into clinical practice for the management of autoimmunity and inflammatory disorders.

18 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YRYesheswini Rajendran
Yesheswini Rajendran
BSBhagyashree Srivastava
Bhagyashree Srivastava
PGPreksha Gaur
Preksha Gaur
RBRohan Babar
Rohan Babar
NGNeha Guliya
Neha Guliya
CSChittur V. Srikanth
Chittur V. Srikanth
Ulcerative colitis, a form of Inflammatory Bowel Disease, is a chronic, relapsing, immune-mediated gut disorder. The intestinal mucus barrier shields the epithelium from luminal microbes and antigens. Sustained mucus layer disruption may drive IBD pathogenesis. Loss of mucin-producing goblet cells is a hallmark of UC. The molecular basis of goblet cell regulation remains unclear. In the current work, we show the role of NCoR1 in goblet cell regulation. Reduced NCoR1 was observed in intestinal crypts and goblet cells of human UC and mice models. NCoR1 affected goblet cell differentiation, and inflammatory cues downregulated its expression. Experimental loss of NCoR1 resulted in exacerbated colitis, whereas its upregulation via Vitamin D rescued murine colitis. KLF-16 was identified as a target of NCoR1. NCoR1-KLF16 axis regulated key goblet cell proteins, including MUC2, via mTOR signalling. In conclusion, this work demonstrates a crucial involvement of NCoR1-KLF16 in governing goblet cell function and intestinal homeostasis.